Says Bilchick, This study adds to our knowledge of the effect of these GLP-1 receptor agonists on reducing morbidity, mortality, and now, in this large study, reducing incident atrial fibrillation over the long term. More research is still needed, especially regarding how different GLP-1 medications, doses, and treatment durations affect weight loss, inflammation, glucose control, Afib risk, and long-term cardiovascular health
MJo, J.O., et al., Thymosin 4 induces the expression of vascular endothelial growth factor (VEGF) in a hypoxia-inducible factor (HIF)-1-dependent manner
Bupropion is a norepinephrine-dopamine reuptake inhibitor (NDRI) that suppresses appetite, increases energy expenditure, and can improve mood
Most of the research in this area has focused specifically on alcohol addiction, and researchers have known for a while now from animal studies that GLP-1 receptor agonists decrease alcohol intake, reduce the motivation to consume alcohol, and even prevent relapse drinking by potentially lowering alcohol-induced reward
Data Availability The datasets generated and/or analyzed during the current study are not publicly available